Cargando…
RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma
Receptor activity modifying protein 1 (RAMP1) facilitates the localization of the calcitonin-like receptor (CLR) to the plasma membrane, but its role in osteosarcoma (OS) remains unclear. We evaluated the RAMP1 expression and prognostic value across different cancers, studying tumor immune infiltrat...
Autores principales: | Xie, Long, Xiao, Weiwei, Fang, Hangqi, Liu, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553254/ https://www.ncbi.nlm.nih.gov/pubmed/37796823 http://dx.doi.org/10.1371/journal.pone.0292452 |
Ejemplares similares
-
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
por: Song, Yang, et al.
Publicado: (2021) -
Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023) -
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022) -
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022) -
HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer
por: Tian, Yonggang, et al.
Publicado: (2022)